Selection from HEOR Bibliography
| Search criteria | ||||
| Luxembourg |
||||
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
| Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
| 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
| JHEOR 2017;5(1):89-108 |
||||
| , Article | ||||
| , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
| Discovery Benelux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia. | ||||
| Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G | ||||
| Acta Cardiologica, 2008, 63(4): 493-499 |
||||
| , Article | ||||
| , Belgium, Luxembourg, Luxemburg, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2008 | English | , Economic evaluation | |